Takeda Pharmaceutical Co has presented PHASE III on a new diabetes compound called fasiglifam.TAK 875

New Drug Approvals

Takeda's diabetes drug fasiglifam shines in Phase III

TAK 875

http://www.ama-assn.org/resources/doc/usan/fasiglifam.pdf GET CAS NO STR MW, ETC HERE

Takeda Pharmaceutical Co has presented positive late-stage data on a new diabetes compound called fasiglifam.

The company announced results of a Phase III trial at the Japan Diabetes Society meeting in Kumamoto,

read all at

http://www.pharmatimes.com/Article/13-05-20/Takeda_s_diabetes_drug_fasiglifam_shines_in_Phase_III.aspx

View original post

Advertisements

About luciavazine

PHARMA PROFESSIONAL, ITALY
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s